Global Agrobacterium tumefaciens Competent Cells 麻豆原创 Research Report 2023

Publication ID:

PB510234336

Publication Date:

October 3, 2023

Pages:

105

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Agrobacterium tumefaciens (Rhizobium radiobactor) is capable of T-DNA transfer to plant cells. The T-DNA (transfer DNA) is located in the Ti plasmid and is capable of integration into the host plant chromosomal DNA.
The global Agrobacterium tumefaciens Competent Cells market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Agrobacterium tumefaciens Competent Cells market research.
Key manufacturers engaged in the Agrobacterium tumefaciens Competent Cells industry include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Agrobacterium tumefaciens Competent Cells were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Agrobacterium tumefaciens Competent Cells market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Agrobacterium tumefaciens Competent Cells market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Segment by Type
20*100渭濒
50*100渭濒
100*100渭濒
Other
Segment by Application
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Agrobacterium tumefaciens Competent Cells report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, 麻豆原创 Channel and Customer Analysis
Chapter 8: 麻豆原创 Opportunities and Challenges
Chapter 9: 麻豆原创 Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Agrobacterium tumefaciens Competent Cells 麻豆原创 Overview
1.1 Product Overview and Scope of Agrobacterium tumefaciens Competent Cells
1.2 Agrobacterium tumefaciens Competent Cells Segment by Type
1.2.1 Global Agrobacterium tumefaciens Competent Cells 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 20*100渭濒
1.2.3 50*100渭濒
1.2.4 100*100渭濒
1.2.5 Other
1.3 Agrobacterium tumefaciens Competent Cells Segment by Application
1.3.1 Global Agrobacterium tumefaciens Competent Cells 麻豆原创 Value by Application: (2023-2029)
1.3.2 Mutagenesis
1.3.3 Single-Stranded Dna Production
1.3.4 Bacmid creation
1.3.5 Cre-lox recombination (PIR1/PIR2)
1.4 Global Agrobacterium tumefaciens Competent Cells 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Agrobacterium tumefaciens Competent Cells Revenue 2018-2029
1.4.2 Global Agrobacterium tumefaciens Competent Cells Sales 2018-2029
1.4.3 Global Agrobacterium tumefaciens Competent Cells 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Agrobacterium tumefaciens Competent Cells 麻豆原创 Competition by Manufacturers
2.1 Global Agrobacterium tumefaciens Competent Cells Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Agrobacterium tumefaciens Competent Cells Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Agrobacterium tumefaciens Competent Cells Average Price by Manufacturers (2018-2023)
2.4 Global Agrobacterium tumefaciens Competent Cells Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Agrobacterium tumefaciens Competent Cells, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Agrobacterium tumefaciens Competent Cells, Product Type & Application
2.7 Agrobacterium tumefaciens Competent Cells 麻豆原创 Competitive Situation and Trends
2.7.1 Agrobacterium tumefaciens Competent Cells 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Agrobacterium tumefaciens Competent Cells Players 麻豆原创 Share by Revenue
2.7.3 Global Agrobacterium tumefaciens Competent Cells 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Agrobacterium tumefaciens Competent Cells Retrospective 麻豆原创 Scenario by Region
3.1 Global Agrobacterium tumefaciens Competent Cells 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Agrobacterium tumefaciens Competent Cells Global Agrobacterium tumefaciens Competent Cells Sales by Region: 2018-2029
3.2.1 Global Agrobacterium tumefaciens Competent Cells Sales by Region: 2018-2023
3.2.2 Global Agrobacterium tumefaciens Competent Cells Sales by Region: 2024-2029
3.3 Global Agrobacterium tumefaciens Competent Cells Global Agrobacterium tumefaciens Competent Cells Revenue by Region: 2018-2029
3.3.1 Global Agrobacterium tumefaciens Competent Cells Revenue by Region: 2018-2023
3.3.2 Global Agrobacterium tumefaciens Competent Cells Revenue by Region: 2024-2029
3.4 North America Agrobacterium tumefaciens Competent Cells 麻豆原创 Facts & Figures by Country
3.4.1 North America Agrobacterium tumefaciens Competent Cells 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Agrobacterium tumefaciens Competent Cells Sales by Country (2018-2029)
3.4.3 North America Agrobacterium tumefaciens Competent Cells Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Agrobacterium tumefaciens Competent Cells 麻豆原创 Facts & Figures by Country
3.5.1 Europe Agrobacterium tumefaciens Competent Cells 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Agrobacterium tumefaciens Competent Cells Sales by Country (2018-2029)
3.5.3 Europe Agrobacterium tumefaciens Competent Cells Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Agrobacterium tumefaciens Competent Cells 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Agrobacterium tumefaciens Competent Cells 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Agrobacterium tumefaciens Competent Cells Sales by Country (2018-2029)
3.6.3 Asia Pacific Agrobacterium tumefaciens Competent Cells Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Agrobacterium tumefaciens Competent Cells 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Agrobacterium tumefaciens Competent Cells 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Agrobacterium tumefaciens Competent Cells Sales by Country (2018-2029)
3.7.3 Latin America Agrobacterium tumefaciens Competent Cells Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Agrobacterium tumefaciens Competent Cells 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Agrobacterium tumefaciens Competent Cells 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Agrobacterium tumefaciens Competent Cells Sales by Country (2018-2029)
3.8.3 Middle East and Africa Agrobacterium tumefaciens Competent Cells Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Agrobacterium tumefaciens Competent Cells Sales by Type (2018-2029)
4.1.1 Global Agrobacterium tumefaciens Competent Cells Sales by Type (2018-2023)
4.1.2 Global Agrobacterium tumefaciens Competent Cells Sales by Type (2024-2029)
4.1.3 Global Agrobacterium tumefaciens Competent Cells Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Agrobacterium tumefaciens Competent Cells Revenue by Type (2018-2029)
4.2.1 Global Agrobacterium tumefaciens Competent Cells Revenue by Type (2018-2023)
4.2.2 Global Agrobacterium tumefaciens Competent Cells Revenue by Type (2024-2029)
4.2.3 Global Agrobacterium tumefaciens Competent Cells Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Agrobacterium tumefaciens Competent Cells Price by Type (2018-2029)
5 Segment by Application
5.1 Global Agrobacterium tumefaciens Competent Cells Sales by Application (2018-2029)
5.1.1 Global Agrobacterium tumefaciens Competent Cells Sales by Application (2018-2023)
5.1.2 Global Agrobacterium tumefaciens Competent Cells Sales by Application (2024-2029)
5.1.3 Global Agrobacterium tumefaciens Competent Cells Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Agrobacterium tumefaciens Competent Cells Revenue by Application (2018-2029)
5.2.1 Global Agrobacterium tumefaciens Competent Cells Revenue by Application (2018-2023)
5.2.2 Global Agrobacterium tumefaciens Competent Cells Revenue by Application (2024-2029)
5.2.3 Global Agrobacterium tumefaciens Competent Cells Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Agrobacterium tumefaciens Competent Cells Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck KGaA
6.1.1 Merck KGaA Corporation Information
6.1.2 Merck KGaA Description and Business Overview
6.1.3 Merck KGaA Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck KGaA Agrobacterium tumefaciens Competent Cells Product Portfolio
6.1.5 Merck KGaA Recent Developments/Updates
6.2 Thermo Fisher Scientific
6.2.1 Thermo Fisher Scientific Corporation Information
6.2.2 Thermo Fisher Scientific Description and Business Overview
6.2.3 Thermo Fisher Scientific Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Thermo Fisher Scientific Agrobacterium tumefaciens Competent Cells Product Portfolio
6.2.5 Thermo Fisher Scientific Recent Developments/Updates
6.3 Agilent Technologies
6.3.1 Agilent Technologies Corporation Information
6.3.2 Agilent Technologies Description and Business Overview
6.3.3 Agilent Technologies Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Agilent Technologies Agrobacterium tumefaciens Competent Cells Product Portfolio
6.3.5 Agilent Technologies Recent Developments/Updates
6.4 Takara Bio
6.4.1 Takara Bio Corporation Information
6.4.2 Takara Bio Description and Business Overview
6.4.3 Takara Bio Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takara Bio Agrobacterium tumefaciens Competent Cells Product Portfolio
6.4.5 Takara Bio Recent Developments/Updates
6.5 Promega Corporation
6.5.1 Promega Corporation Corporation Information
6.5.2 Promega Corporation Description and Business Overview
6.5.3 Promega Corporation Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Promega Corporation Agrobacterium tumefaciens Competent Cells Product Portfolio
6.5.5 Promega Corporation Recent Developments/Updates
6.6 Beijing TransGen Biotech
6.6.1 Beijing TransGen Biotech Corporation Information
6.6.2 Beijing TransGen Biotech Description and Business Overview
6.6.3 Beijing TransGen Biotech Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Beijing TransGen Biotech Agrobacterium tumefaciens Competent Cells Product Portfolio
6.6.5 Beijing TransGen Biotech Recent Developments/Updates
6.7 GeneScript Corporation
6.6.1 GeneScript Corporation Corporation Information
6.6.2 GeneScript Corporation Description and Business Overview
6.6.3 GeneScript Corporation Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GeneScript Corporation Agrobacterium tumefaciens Competent Cells Product Portfolio
6.7.5 GeneScript Corporation Recent Developments/Updates
6.8 Yeastern Biotech
6.8.1 Yeastern Biotech Corporation Information
6.8.2 Yeastern Biotech Description and Business Overview
6.8.3 Yeastern Biotech Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Yeastern Biotech Agrobacterium tumefaciens Competent Cells Product Portfolio
6.8.5 Yeastern Biotech Recent Developments/Updates
6.9 New England Biolabs
6.9.1 New England Biolabs Corporation Information
6.9.2 New England Biolabs Description and Business Overview
6.9.3 New England Biolabs Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.9.4 New England Biolabs Agrobacterium tumefaciens Competent Cells Product Portfolio
6.9.5 New England Biolabs Recent Developments/Updates
6.10 QIAGEN N.V.
6.10.1 QIAGEN N.V. Corporation Information
6.10.2 QIAGEN N.V. Description and Business Overview
6.10.3 QIAGEN N.V. Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.10.4 QIAGEN N.V. Agrobacterium tumefaciens Competent Cells Product Portfolio
6.10.5 QIAGEN N.V. Recent Developments/Updates
6.11 OriGene Technologies
6.11.1 OriGene Technologies Corporation Information
6.11.2 OriGene Technologies Agrobacterium tumefaciens Competent Cells Description and Business Overview
6.11.3 OriGene Technologies Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.11.4 OriGene Technologies Agrobacterium tumefaciens Competent Cells Product Portfolio
6.11.5 OriGene Technologies Recent Developments/Updates
6.12 Lucigen
6.12.1 Lucigen Corporation Information
6.12.2 Lucigen Agrobacterium tumefaciens Competent Cells Description and Business Overview
6.12.3 Lucigen Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Lucigen Agrobacterium tumefaciens Competent Cells Product Portfolio
6.12.5 Lucigen Recent Developments/Updates
6.13 Zymo Research
6.13.1 Zymo Research Corporation Information
6.13.2 Zymo Research Agrobacterium tumefaciens Competent Cells Description and Business Overview
6.13.3 Zymo Research Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Zymo Research Agrobacterium tumefaciens Competent Cells Product Portfolio
6.13.5 Zymo Research Recent Developments/Updates
6.14 Bio-Rad Laboratories
6.14.1 Bio-Rad Laboratories Corporation Information
6.14.2 Bio-Rad Laboratories Agrobacterium tumefaciens Competent Cells Description and Business Overview
6.14.3 Bio-Rad Laboratories Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Bio-Rad Laboratories Agrobacterium tumefaciens Competent Cells Product Portfolio
6.14.5 Bio-Rad Laboratories Recent Developments/Updates
6.15 Bioline
6.15.1 Bioline Corporation Information
6.15.2 Bioline Agrobacterium tumefaciens Competent Cells Description and Business Overview
6.15.3 Bioline Agrobacterium tumefaciens Competent Cells Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Bioline Agrobacterium tumefaciens Competent Cells Product Portfolio
6.15.5 Bioline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Agrobacterium tumefaciens Competent Cells Industry Chain Analysis
7.2 Agrobacterium tumefaciens Competent Cells Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Agrobacterium tumefaciens Competent Cells Production Mode & Process
7.4 Agrobacterium tumefaciens Competent Cells Sales and 麻豆原创ing
7.4.1 Agrobacterium tumefaciens Competent Cells Sales Channels
7.4.2 Agrobacterium tumefaciens Competent Cells Distributors
7.5 Agrobacterium tumefaciens Competent Cells Customers
8 Agrobacterium tumefaciens Competent Cells 麻豆原创 Dynamics
8.1 Agrobacterium tumefaciens Competent Cells Industry Trends
8.2 Agrobacterium tumefaciens Competent Cells 麻豆原创 Drivers
8.3 Agrobacterium tumefaciens Competent Cells 麻豆原创 Challenges
8.4 Agrobacterium tumefaciens Competent Cells 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.